Evaluation of biomarkers for in vitro prediction of drug-induced nephrotoxicity in RPTEC/TERT1 cells
Open Access
- 24 April 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicology Research
- Vol. 9 (2) , 91-100
Abstract
There have been intensive efforts to identify in vivo biomarkers that can be used to monitor drug-induced kidney damage before significant impairment occurs. Kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, clusterin, β2-microglobulin and cystatin C (CysC) have been validated as clinical or preclinical biomarkers in urinary and plasma predictive of acute and chronic kidney injuries and diseases. A high-throughput in vitro assay predictive of nephrotoxicity could potentially be implemented in early drug discovery stage to reduce attrition at later stages of drug development. To assess the potential of these known in vivo biomarkers for in vitro evaluation of drug-induced nephrotoxicity, we selected four nephrotoxic agents (cisplatin, cyclosporin, aristolochic acid I and gentamicin) and detected their effects on the protein levels of nephrotoxic biomarkers in RPTEC/TERT1 cells. The protein levels of clusterin, CysC, GSTπ and TIMP-1 significantly increased in the conditioned media of RPTEC/TERT1 cells treated with cisplatin, cyclosporin, aristolochic acid I and gentamicin. The messenger RNA levels of clusterin, CysC, GSTπ and TIMP-1 also increased in RPTEC/TERT1 cells treated with cisplatin, cyclosporin, aristolochic acid I and gentamicin, indicating that drug-induced upregulation involves transcriptional activation. Taken together, the results clearly demonstrate that among the known in vivo nephrotoxic biomarkers, clusterin, CysC, GSTπ and TIMP-1 can be effectively used as in vitro biomarkers for drug-induced nephrotoxicity in RPTEC/TERT1 cells.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2018ZX09201017-001)
- National Natural Science Foundation of China (81603210)
This publication has 23 references indexed in Scilit:
- Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional frameworkNature Reviews Drug Discovery, 2014
- Identification of Nephrotoxic Compounds with Embryonic Stem-Cell-Derived Human Renal Proximal Tubular-Like CellsMolecular Pharmaceutics, 2014
- An in vitro method for the prediction of renal proximal tubular toxicity in humansToxicology Research, 2013
- Gadolinium modulates gentamicin uptake via an endocytosis-independent pathway in HK-2 human renal proximal tubular cell lineEuropean Journal of Pharmacology, 2012
- Towards consensus practices to qualify safety biomarkers for use in early drug developmentNature Biotechnology, 2010
- Next-generation biomarkers for detecting kidney toxicityNature Biotechnology, 2010
- Impact of biomarker development on drug safety assessmentToxicology and Applied Pharmacology, 2010
- hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristicsAmerican Journal of Physiology-Renal Physiology, 2008
- Evaluation of Putative Biomarkers of Nephrotoxicity after Exposure to Ochratoxin A In Vivo and In VitroToxicological Sciences, 2008
- Drug-associated renal dysfunction and injuryNature Clinical Practice Nephrology, 2006